Correlation Between Sharps Technology and GlucoTrack
Can any of the company-specific risk be diversified away by investing in both Sharps Technology and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sharps Technology and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sharps Technology and GlucoTrack, you can compare the effects of market volatilities on Sharps Technology and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sharps Technology with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sharps Technology and GlucoTrack.
Diversification Opportunities for Sharps Technology and GlucoTrack
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sharps and GlucoTrack is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sharps Technology and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and Sharps Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sharps Technology are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of Sharps Technology i.e., Sharps Technology and GlucoTrack go up and down completely randomly.
Pair Corralation between Sharps Technology and GlucoTrack
Given the investment horizon of 90 days Sharps Technology is expected to under-perform the GlucoTrack. But the stock apears to be less risky and, when comparing its historical volatility, Sharps Technology is 1.77 times less risky than GlucoTrack. The stock trades about -0.05 of its potential returns per unit of risk. The GlucoTrack is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 623.00 in GlucoTrack on November 2, 2024 and sell it today you would lose (616.24) from holding GlucoTrack or give up 98.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sharps Technology vs. GlucoTrack
Performance |
Timeline |
Sharps Technology |
GlucoTrack |
Sharps Technology and GlucoTrack Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sharps Technology and GlucoTrack
The main advantage of trading using opposite Sharps Technology and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sharps Technology position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.Sharps Technology vs. JIN MEDICAL INTERNATIONAL | Sharps Technology vs. Meihua International Medical | Sharps Technology vs. GlucoTrack | Sharps Technology vs. Innovative Eyewear |
GlucoTrack vs. Nexgel Inc | GlucoTrack vs. Avinger | GlucoTrack vs. Sharps Technology | GlucoTrack vs. Innovative Eyewear |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world |